GSK3145095 is a RIP1 kinase inhibitor with an IC50 of 6.3 nM . References: Harris PA, ET AL. Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer. ACS Med Chem Lett. 2019 May 9;10(6):857-862.

纯度：≥98%

CAS：1622849-43-7